PortfoliosLab logoPortfoliosLab logo
CAT vs. AXSM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CAT vs. AXSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Caterpillar Inc. (CAT) and Axsome Therapeutics, Inc. (AXSM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CAT achieves a 72.82% return, which is significantly higher than AXSM's 37.16% return. Over the past 10 years, CAT has underperformed AXSM with an annualized return of 32.10%, while AXSM has yielded a comparatively higher 44.83% annualized return.


CAT

1D
3.13%
1M
12.04%
YTD
72.82%
6M
71.81%
1Y
176.40%
3Y*
61.41%
5Y*
38.86%
10Y*
32.10%

AXSM

1D
-0.66%
1M
6.16%
YTD
37.16%
6M
64.10%
1Y
148.78%
3Y*
43.37%
5Y*
30.05%
10Y*
44.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CAT vs. AXSM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CAT
Caterpillar Inc.
72.82%60.30%24.66%25.95%18.60%15.95%26.97%19.51%-17.56%75.03%
AXSM
Axsome Therapeutics, Inc.
37.16%115.86%6.31%3.19%104.16%-53.63%-21.18%3,565.25%-49.64%-17.04%

Correlation

The correlation between CAT and AXSM is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Nov 19, 2015

0.16

Fundamentals

Market Cap

CAT:

$459.19B

AXSM:

$12.83B

EPS

CAT:

$20.07

AXSM:

-$3.74

PS Ratio

CAT:

6.54

AXSM:

17.80

PB Ratio

CAT:

24.61

AXSM:

234.95

Total Revenue (TTM)

CAT:

$70.76B

AXSM:

$708.24M

Gross Profit (TTM)

CAT:

$23.01B

AXSM:

$655.82M

EBITDA (TTM)

CAT:

$15.31B

AXSM:

-$172.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CAT vs. AXSM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CAT
CAT Risk / Return Rank: 9898
Overall Rank
CAT Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
CAT Sortino Ratio Rank: 9898
Sortino Ratio Rank
CAT Omega Ratio Rank: 9898
Omega Ratio Rank
CAT Calmar Ratio Rank: 9898
Calmar Ratio Rank
CAT Martin Ratio Rank: 9999
Martin Ratio Rank

AXSM
AXSM Risk / Return Rank: 9797
Overall Rank
AXSM Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
AXSM Sortino Ratio Rank: 9797
Sortino Ratio Rank
AXSM Omega Ratio Rank: 9696
Omega Ratio Rank
AXSM Calmar Ratio Rank: 9696
Calmar Ratio Rank
AXSM Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CAT vs. AXSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Caterpillar Inc. (CAT) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CATAXSMDifference
Sharpe ratioReturn per unit of total volatility

+1.59

Sortino ratioReturn per unit of downside risk

+0.64

Omega ratioGain probability vs. loss probability

1.71

1.58

+0.13

Calmar ratioReturn relative to maximum drawdown

12.83

7.80

+5.03

Martin ratioReturn relative to average drawdown

42.03

22.99

+19.04

CAT vs. AXSM - Sharpe Ratio Comparison

The current CAT Sharpe Ratio is 5.05, which is higher than the AXSM Sharpe Ratio of 3.46. The chart below compares the historical Sharpe Ratios of CAT and AXSM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CAT vs. AXSM - Drawdown Comparison

The maximum CAT drawdown since its inception was -73.43%, smaller than the maximum AXSM drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for CAT and AXSM.


Loading charts...

Drawdown Indicators


CATAXSMDifference

Max Drawdown

Largest peak-to-trough decline

-73.43%

-86.65%

+13.22%

Max Drawdown (1Y)

Largest decline over 1 year

-13.88%

-18.50%

+4.62%

Max Drawdown (3Y)

Largest decline over 3 years

-34.05%

-34.83%

+0.78%

Max Drawdown (5Y)

Largest decline over 5 years

-34.05%

-72.91%

+38.86%

Max Drawdown (10Y)

Largest decline over 10 years

-43.36%

-81.26%

+37.90%

Current Drawdown

Current decline from peak

0.00%

-1.83%

+1.83%

Average Drawdown

Average peak-to-trough decline

-19.73%

-39.42%

+19.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.23%

6.27%

-2.04%

Volatility

CAT vs. AXSM - Volatility Comparison

Caterpillar Inc. (CAT) has a higher volatility of 12.57% compared to Axsome Therapeutics, Inc. (AXSM) at 8.89%. This indicates that CAT's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CATAXSMDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.57%

8.89%

+3.68%

Volatility (6M)

Calculated over the trailing 6-month period

28.09%

33.12%

-5.03%

Volatility (1Y)

Calculated over the trailing 1-year period

35.27%

41.72%

-6.45%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.80%

70.26%

-39.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.00%

90.42%

-59.42%

Dividends

CAT vs. AXSM - Dividend Comparison

CAT's dividend yield for the trailing twelve months is around 0.61%, while AXSM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AXSM
Axsome Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CAT
Caterpillar Inc.
0.61%1.02%1.49%1.69%1.93%2.07%2.26%2.56%2.58%1.97%3.32%4.33%

Financials

CAT vs. AXSM - Financials Comparison

This section allows you to compare key financial metrics between Caterpillar Inc. and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
17.42B
191.20M
(CAT) Total Revenue
(AXSM) Total Revenue
Values in USD except per share items

CAT vs. AXSM - Profitability Comparison

The chart below illustrates the profitability comparison between Caterpillar Inc. and Axsome Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
35.1%
92.3%
Portfolio components
CAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Caterpillar Inc. reported a gross profit of 6.11B and revenue of 17.42B. Therefore, the gross margin over that period was 35.1%.

AXSM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.

CAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Caterpillar Inc. reported an operating income of 3.09B and revenue of 17.42B, resulting in an operating margin of 17.7%.

AXSM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.

CAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Caterpillar Inc. reported a net income of 2.55B and revenue of 17.42B, resulting in a net margin of 14.6%.

AXSM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.


Frequently Asked Questions


CAT and AXSM have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CAT has higher volatility (12.57%) compared to AXSM (8.89%). In terms of maximum drawdown, CAT dropped -73.43% vs AXSM's -86.65%.

CAT currently has the higher Sharpe Ratio (5.05 vs 3.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CAT and AXSM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer